Zantac 150 and Tobramycin sulfate drug interactions - from FDA reports


Summary

Drug interactions are reported among people who take Zantac 150 and Tobramycin sulfate together. This review analyzes the effectiveness and drug interactions between Zantac 150 and Tobramycin sulfate. It is created by eHealthMe based on reports of 124 people who take the same drugs from FDA, and is updated regularly.

What to expect?

If you take Zantac 150 and Tobramycin sulfate, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Zantac 150 and Tobramycin sulfate

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

Zantac 150

Zantac 150 has active ingredients of ranitidine hydrochloride. It is often used in gastroesophageal reflux disease. (latest outcomes from Zantac 150 4,269 users)

Tobramycin Sulfate

Tobramycin sulfate has active ingredients of tobramycin sulfate. (latest outcomes from Tobramycin sulfate 295 users)

On Feb, 22, 2017

124 people who take Zantac 150, Tobramycin Sulfate are studied.


Number of reports submitted per year:

Zantac 150 and Tobramycin sulfate drug interactions.

Most common drug interactions over time *:

< 1 month:
  • neutropenia
  • malaise
  • febrile neutropenia
  • diarrhoea
  • ileus
  • multi-organ failure
  • vomiting
  • anxiety
  • depression
  • drug ineffective
2 - 5 years:
  • colostomy
not specified:
  • pyrexia
  • atrial fibrillation
  • acute generalised exanthematous pustulosis
  • haemoglobin decreased
  • multi-organ failure
  • febrile neutropenia
  • pseudomonas infection
  • oral candidiasis
  • pneumonia
  • weight decreased

Most common drug interactions by gender *:

female:
  • neutropenia
  • febrile neutropenia
  • pyrexia
  • cough
  • nausea
  • pseudomonas infection
  • accidental overdose (therapeutic agent)
  • atrial fibrillation
  • blister
  • c-reactive protein increased
male:
  • febrile neutropenia
  • multi-organ failure
  • acute generalised exanthematous pustulosis
  • atrial fibrillation
  • back pain
  • haemoglobin decreased
  • pneumonia
  • weight decreased
  • abdominal discomfort
  • blood culture positive

Most common drug interactions by age *:

0-1:
  • catheter sepsis
  • enterococcal sepsis
  • drug ineffective
  • extravasation
  • haemodynamic instability
  • infusion site pain
  • infusion site swelling
  • intraventricular haemorrhage
  • intraventricular haemorrhage neonatal
  • neonatal disorder
2-9:
  • ammonia increased
  • ascites
  • blood bilirubin increased
  • death
  • depressed level of consciousness
  • eyelid ptosis
  • hepatomegaly
  • jaundice
  • pleural effusion
  • seizure
10-19:
  • blister
  • corneal erosion
  • multi-organ failure
  • pyrexia
  • stevens johnson syndrome
  • oral mucosal blistering
  • epidermal necrolysis
  • rash maculo-papular
  • acute circulatory failure
  • arthralgia
20-29:
  • accidental overdose (therapeutic agent)
  • c-reactive protein increased
  • graft rejection
  • pyrexia
  • tachypnoea
  • bronchial obstruction
  • bronchoscopy abnormal
  • infective pulmonary exacerbation of cystic fibrosis
  • nausea
  • pulmonary vascular resistance abnormality
30-39:
  • diarrhoea
  • febrile neutropenia
  • ileus
  • multi-organ failure
  • vomiting
  • anxiety
  • depression
  • drug ineffective
  • renal failure acute
  • acute lymphocytic leukaemia
40-49:
  • neutropenia
  • febrile neutropenia
  • immunosuppressant drug level increased
  • pancreatitis acute
  • splenomegaly
  • abdominal discomfort
  • abdominal distension
  • acute respiratory distress syndrome
  • agitation
  • anasarca
50-59:
  • neutropenia
  • febrile neutropenia
  • device related infection
  • erythema
  • laryngospasm
  • rash macular
  • rigors
  • toxic epidermal necrolysis
60+:
  • atrial fibrillation
  • acute generalised exanthematous pustulosis
  • haemoglobin decreased
  • febrile neutropenia
  • pseudomonas infection
  • oral candidiasis
  • blood culture positive
  • haematocrit decreased
  • streptococcal infection
  • unresponsive to stimuli

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Zantac 150 and Tobramycin sulfate?

Interactions between Zantac 150 and drugs from A to Z

a b c d e f g h i j k l m n o p q r s t u v w x y z

Interactions between Tobramycin sulfate and drugs from A to Z

a b c d e f g h i j k l m n o p q r s t u v w x y z

On eHealthMe, Zantac 150 (ranitidine hydrochloride) is often used to treat indigestion. Tobramycin sulfate (tobramycin sulfate) is often used to treat infection. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:

Can you answer these questions?

More questions for: Zantac 150, Tobramycin sulfate

You may be interested in these reviews

More reviews for: Zantac 150, Tobramycin sulfate